A full-year outlook will be provided with Q1 2025 results in May, allowing for further assessment of progress in key initiatives. Revenue for Q4 2024 was $39.2 million, a decrease of 17.7% ...

Docusign's mixed earnings report shows EPS and revenue beats but slowed growth. Click here to read an analysis of DOCU stock ...

Becker's has reported on three health systems that have named new chief revenue officers in 2025: ...

Its fourth quarter results are in the books and Paradigm Capital analyst Daniel Rosenberg thinks there is still a lot of ...